×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Fertility Testing Market

ID: MRFR/LS/14242-HCR
100 Pages
Rahul Gotadki
October 2025

US Fertility Testing Market Research Report By Product (Ovulation Predictor Kits, Fertility Monitors, Male Fertility Testing Products, others), By Sample (Saliva, Urine, Blood, others), By Mode of Purchase (Prescription-Based, OTC-Based) and By End-User (Home Care Settings, Hospitals, Fertility Clinics, others) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Fertility Testing Market Infographic
Purchase Options

US Fertility Testing Market Summary

As per MRFR analysis, the US fertility testing market Size was estimated at 171.4 USD Million in 2024. The US fertility testing market is projected to grow from 185.3 USD Million in 2025 to 404.33 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.11% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US fertility testing market is experiencing a transformative shift towards more accessible and technologically advanced solutions.

  • The rise of at-home testing kits is reshaping consumer engagement in the fertility testing landscape.
  • Integration of digital health technologies is enhancing the accuracy and convenience of fertility assessments.
  • Increased focus on male fertility is emerging as a significant trend, reflecting changing societal norms around family planning.
  • Key market drivers include growing awareness of fertility issues and technological advancements in testing methods.

Market Size & Forecast

2024 Market Size 171.4 (USD Million)
2035 Market Size 404.33 (USD Million)

Major Players

Thermo Fisher Scientific (US), Ferring Pharmaceuticals (DK), Merck KGaA (DE), CooperSurgical (US), IVF Technologies (US), Genea Limited (AU), HRC Fertility (US), OvaScience (US), Reproductive Health Technologies (US)

US Fertility Testing Market Trends

The fertility testing market is currently experiencing notable growth, driven by increasing awareness surrounding reproductive health and advancements in technology. Individuals and couples are becoming more proactive in understanding their fertility status, leading to a rise in demand for various testing options. This trend is further supported by educational initiatives and resources that aim to inform the public about fertility issues. As a result, a diverse range of products, including at-home testing kits and laboratory services, are becoming more accessible to consumers. Moreover, the landscape of the fertility testing market is evolving with the integration of digital health solutions. Mobile applications and telehealth services are emerging as valuable tools for individuals seeking guidance and support in their fertility journeys. These innovations not only enhance user experience but also facilitate better communication between patients and healthcare providers. The combination of increased consumer interest and technological advancements suggests a promising future for the fertility testing market, as it adapts to meet the needs of a growing population seeking reproductive health solutions.

Rise of At-Home Testing Kits

The trend towards at-home fertility testing kits is gaining traction, as consumers seek convenience and privacy in assessing their reproductive health. These kits allow individuals to conduct tests in the comfort of their homes, providing immediate results and reducing the need for clinical visits. This shift reflects a broader desire for accessible healthcare solutions.

Integration of Digital Health Technologies

Digital health technologies are increasingly being integrated into the fertility testing market, enhancing the way individuals manage their reproductive health. Mobile applications and online platforms offer personalized insights, tracking capabilities, and educational resources, empowering users to make informed decisions regarding their fertility.

Increased Focus on Male Fertility

There is a growing recognition of male fertility issues, leading to an increased focus on testing and treatment options for men. This trend highlights the importance of addressing both partners' reproductive health, fostering a more inclusive approach to fertility challenges and expanding the market for male-specific testing solutions.

US Fertility Testing Market Drivers

Rising Healthcare Expenditures

Rising healthcare expenditures in the US are driving growth in the fertility testing market. As individuals allocate more resources towards health and wellness, spending on fertility-related services and products is increasing. In recent years, healthcare spending has risen by approximately 4-5% annually, with a notable portion directed towards reproductive health. This trend indicates a willingness among consumers to invest in fertility testing as part of their overall health management. The fertility testing market stands to gain from this increase in healthcare spending, as more individuals seek proactive measures to address fertility concerns. Additionally, insurance coverage for fertility testing is gradually improving, further encouraging individuals to pursue testing options and contributing to market growth.

Growing Awareness of Fertility Issues

The increasing awareness surrounding fertility issues is a pivotal driver for the fertility testing market. As more individuals and couples recognize the challenges associated with conception, there is a corresponding rise in demand for fertility testing solutions. Educational campaigns and social media discussions have contributed to this heightened awareness, leading to a more informed public. In the US, approximately 10-15% of couples experience infertility, which translates to millions seeking assistance. This growing recognition of fertility challenges is likely to propel the market forward, as individuals actively seek testing options to understand their reproductive health better. The fertility testing market is thus positioned to benefit from this trend, as more people prioritize their reproductive health and seek out testing solutions to address their concerns.

Changing Societal Norms and Family Planning

Changing societal norms regarding family planning are reshaping the fertility testing market. As more individuals prioritize career and personal development before starting families, there is a growing trend of delayed parenthood. This shift has led to increased awareness of fertility preservation and the importance of understanding one's reproductive health. The fertility testing market is responding to this change by offering a variety of testing options tailored to individuals who may wish to delay childbearing. Furthermore, the rise of single-parent households and diverse family structures is also influencing the demand for fertility testing, as individuals seek to explore their options. This evolving landscape suggests a sustained growth trajectory for the market as it adapts to the changing needs of society.

Increased Access to Information and Resources

Increased access to information and resources is a crucial driver for the fertility testing market. The proliferation of online platforms and educational resources has empowered individuals to learn more about fertility and reproductive health. This accessibility has led to a more informed consumer base that actively seeks fertility testing solutions. The fertility testing market is benefiting from this trend, as individuals are more likely to pursue testing when they have access to reliable information. Additionally, the rise of telehealth services has made it easier for individuals to consult with healthcare professionals regarding fertility testing. This combination of information access and professional guidance is likely to enhance the market's growth, as more people take proactive steps towards understanding and managing their fertility.

Technological Advancements in Testing Methods

Technological advancements in testing methods are significantly influencing the fertility testing market. Innovations such as non-invasive testing techniques and improved accuracy in results are making fertility testing more accessible and reliable. For instance, advancements in hormone testing and genetic screening have enhanced the ability to diagnose fertility issues effectively. The fertility testing market is witnessing a surge in demand for these advanced testing methods, as they offer quicker results and greater convenience for users. Moreover, the integration of artificial intelligence in analyzing test results is expected to further streamline the process, making it easier for individuals to understand their fertility status. As technology continues to evolve, the market is likely to expand, catering to a growing population seeking efficient and accurate fertility testing solutions.

Market Segment Insights

By Product: Ovulation Testing Kit (Largest) vs. Fertility Monitors (Fastest-Growing)

In the US fertility testing market, the segment values display a dynamic range of offerings, with Ovulation Testing Kits commanding the largest share. These kits are widely recognized for their effectiveness in predicting ovulation cycles, contributing to their popularity among consumers. Fertility Monitors have emerged as a competitive alternative, though they currently hold a smaller market share despite their innovative technology and user-friendly features. Growth trends in this segment are promising, primarily driven by increasing awareness and education regarding fertility options among consumers. The demand for Fertility Monitors is particularly escalating, attributed to advancements in technology that offer real-time monitoring and data analysis, attracting tech-savvy individuals. Additionally, changing societal attitudes towards family planning are leading to greater investments in fertility-related products, further boosting market potential.

Ovulation Testing Kit (Dominant) vs. Fertility Monitors (Emerging)

Ovulation Testing Kits are characterized by their widespread appeal and established presence in the market, providing reliable results that are accessible to many consumers. They typically allow users to pinpoint fertile days with ease, making them a go-to option for couples trying to conceive. On the other hand, Fertility Monitors are gaining traction as an emerging segment, appealing to those seeking more comprehensive and technologically sophisticated solutions. These monitors not only track ovulation but may also measure hormonal changes over time, offering a more detailed understanding of one’s fertility status. As awareness of fertility issues continues to rise, both segments stand to benefit, although Ovulation Testing Kits currently maintain a dominant position.

By Gender: Female (Largest) vs. Male (Fastest-Growing)

In the US fertility testing market, the gender segment displays a distinct distribution of market share. Female fertility testing products dominate the market, driven by widespread awareness and demand related to reproductive health. Women are often the primary seekers of fertility solutions, leading to a significant share attributed to this demographic. Conversely, male fertility testing is gaining traction, though it currently holds a smaller proportion of the market share. Growth trends indicate a burgeoning interest in male fertility testing driven by evolving societal norms and an increasing acknowledgment of male reproductive health. This shift is supported by targeted marketing campaigns and the introduction of more accessible testing solutions. As awareness continues to grow, male fertility products are projected to experience the fastest growth in the segment, reflecting changing attitudes towards male responsibilities in reproductive health.

Female: Dominant vs. Male: Emerging

Female fertility testing is characterized by a long-established market presence and widespread use, as women actively seek solutions for reproductive challenges. This segment is bolstered by a variety of products, including ovulation kits and hormone monitoring devices, reflecting the diverse needs of women. In contrast, male fertility testing represents an emerging segment, fueled by societal shifts in recognizing the importance of male genetics and sperm health. Although it currently accounts for a smaller share, increased education and awareness are likely to elevate male testing as a significant component of fertility evaluation, indicating a promising future for male-focused products.

By Distribution Channel: Retail Pharmacy (Largest) vs. Online Pharmacy (Fastest-Growing)

In the US fertility testing market, the distribution of sales among various channels shows Retail Pharmacy as the dominant player, capturing a significant market share due to its accessibility and wide reach. Hospital Pharmacy follows closely, offering reliable options for patients undergoing fertility treatments. Online Pharmacy is gaining traction but remains a smaller segment, driven by the convenience of online shopping and the discretion it offers to users seeking fertility solutions. Growth trends indicate a notable shift towards Online Pharmacy as consumers increasingly prefer purchasing healthcare products digitally. Factors such as the rise of e-commerce, high demand for at-home fertility testing kits, and the ongoing enhancements in online shopping experiences are propelling this segment. Retail Pharmacies, while still dominant, must innovate and enhance their services to retain customers amidst this growing competition from online channels.

Retail Pharmacy (Dominant) vs. Online Pharmacy (Emerging)

Retail Pharmacy remains the dominant channel in the US fertility testing market, primarily due to its established presence and trust among consumers. It caters to a wide demographic, providing a range of fertility products with immediate availability. In contrast, Online Pharmacy is emerging rapidly, leveraging technology to offer convenience and privacy for users. This segment attracts a younger demographic seeking discreet options and home delivery services, significantly altering purchasing patterns. As digital platforms enhance their offerings, Online Pharmacy is expected to further disrupt traditional retail dynamics, pushing Retail Pharmacy to adapt and innovate to maintain its market position.

Get more detailed insights about US Fertility Testing Market

Key Players and Competitive Insights

The fertility testing market is characterized by a dynamic competitive landscape, driven by increasing awareness of reproductive health and advancements in technology. Key players such as Thermo Fisher Scientific (US), CooperSurgical (US), and IVF Technologies (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Thermo Fisher Scientific (US) focuses on innovation through the development of advanced diagnostic tools, while CooperSurgical (US) emphasizes strategic partnerships to expand its product offerings. IVF Technologies (US) is leveraging digital transformation to improve customer engagement and streamline operations, collectively shaping a competitive environment that prioritizes technological advancement and customer-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive innovation and set industry standards, thereby shaping the overall market structure.

In October 2025, Thermo Fisher Scientific (US) announced the launch of a new line of fertility testing kits designed to provide more accurate results in less time. This strategic move is likely to enhance their competitive edge by addressing the growing demand for rapid and reliable testing solutions. The introduction of these kits not only reinforces their commitment to innovation but also positions them favorably against competitors who may not have similar offerings.

In September 2025, CooperSurgical (US) entered into a partnership with a leading telehealth provider to integrate fertility testing services into virtual care platforms. This collaboration is significant as it reflects a shift towards digital health solutions, allowing for greater accessibility and convenience for patients. By aligning with telehealth services, CooperSurgical (US) is likely to capture a broader audience, particularly among younger demographics who prefer remote healthcare options.

In August 2025, IVF Technologies (US) expanded its operations by acquiring a regional fertility clinic, thereby enhancing its service capabilities and geographic reach. This acquisition is strategically important as it not only increases their market share but also allows for the integration of advanced testing technologies into the clinic's existing services. Such moves indicate a trend towards consolidation in the market, where companies seek to enhance their operational footprint and service offerings.

As of November 2025, current trends in the fertility testing market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into testing processes. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these areas are likely to gain a competitive advantage in the rapidly evolving market.

Key Companies in the US Fertility Testing Market market include

Industry Developments

The US Fertility Testing Market has been experiencing notable developments recently, particularly in the area of innovation and partnerships. Progenity continues to expand its portfolio, focusing on non-invasive genetic testing solutions aimed at improving fertility outcomes. Zywave has been enhancing its digital platforms to support fertility tracking and monitoring. Cypress Diagnostics introduced new diagnostic tests that have gained traction among fertility clinics.

In terms of market dynamics, CooperSurgical and LabCorp are exploring collaborative efforts to streamline testing processes, which is expected to enhance patient access to fertility solutions. Thermo Fisher Scientific and SomaLogic are investing in advanced technologies to develop precision fertility testing products. Additionally, Abbott Laboratories and Quest Diagnostics have reported significant growth in their fertility testing services, reflecting an increased demand driven by the rising awareness regarding reproductive health.

In a recent merger, Ferring Pharmaceuticals announced its acquisition of a niche fertility testing firm in May 2023, positioning itself to broaden its offerings in the fertility sector. The overall market is witnessing a growth trend, influenced by technological advancements and increased public interest, particularly among younger demographics concerned with fertility health.

Future Outlook

US Fertility Testing Market Future Outlook

The Fertility Testing Market is projected to grow at an 8.11% CAGR from 2024 to 2035, driven by technological advancements, increasing awareness, and rising infertility rates.

New opportunities lie in:

  • Development of AI-driven fertility assessment tools
  • Expansion of telehealth services for remote consultations
  • Introduction of subscription-based fertility testing kits

By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and technological innovations.

Market Segmentation

US Fertility Testing Market Gender Outlook

  • Male
  • Female

US Fertility Testing Market Product Outlook

  • Ovulation Testing Kit
  • Fertility Monitors
  • Others

US Fertility Testing Market Distribution Channel Outlook

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Report Scope

MARKET SIZE 2024 171.4(USD Million)
MARKET SIZE 2025 185.3(USD Million)
MARKET SIZE 2035 404.33(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.11% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Thermo Fisher Scientific (US), Ferring Pharmaceuticals (DK), Merck KGaA (DE), CooperSurgical (US), IVF Technologies (US), Genea Limited (AU), HRC Fertility (US), OvaScience (US), Reproductive Health Technologies (US)
Segments Covered Product, Gender, Distribution Channel
Key Market Opportunities Integration of advanced digital platforms enhances accessibility and personalization in the fertility testing market.
Key Market Dynamics Rising consumer demand for at-home fertility testing drives innovation and competition among market players.
Countries Covered US

Leave a Comment

FAQs

What is the expected market size of the US Fertility Testing Market in 2024?

The US Fertility Testing Market is expected to be valued at 136.5 million USD in 2024.

How much is the US Fertility Testing Market projected to grow by 2035?

By 2035, the market is projected to reach a valuation of 400.0 million USD.

What is the expected CAGR for the US Fertility Testing Market from 2025 to 2035?

The expected CAGR for the US Fertility Testing Market from 2025 to 2035 is 10.268 percent.

Which segment holds the largest market share in the US Fertility Testing Market?

The Ovulation Predictor Kits segment is anticipated to dominate the market with a value of 45.0 million USD in 2024.

What will be the market size for Male Fertility Testing Products by 2035?

The Male Fertility Testing Products segment is projected to reach 80.0 million USD by 2035.

Who are the key players in the US Fertility Testing Market?

Major players include Progenity, Zywave, CooperSurgical, and LabCorp among others.

What are some growth drivers for the US Fertility Testing Market?

Rising infertility rates and increasing awareness about fertility testing are key growth drivers.

What is the expected market size for Fertility Monitors in 2035?

Fertility Monitors are expected to reach a market size of 100.0 million USD by 2035.

How is the current market environment impacting the US Fertility Testing Market?

Current market trends show a growing demand for home-based fertility testing solutions.

What challenges does the US Fertility Testing Market face?

Challenges include regulatory hurdles and competition from alternative reproductive technologies.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions